Southmead Hospital, Bristol, UK
Bristol Speech and Language Therapy Research Unit, North Bristol NHS Trust, Westbury on Trym, UK.
BMJ Open. 2024 Apr 29;14(4):e081446. doi: 10.1136/bmjopen-2023-081446.
Speech sound disorder (SSD) describes a 'persistent difficulty with speech sound production that interferes with speech intelligibility or prevents verbal communication'. There is a need to establish which care pathways are most effective and efficient for children with SSD. Comparison of care pathways requires clearly defined, evidence-based, interventions and agreement on how to measure the outcomes. At present, no definitive list of assessments, interventions or outcomes exists. The objective of this umbrella review paper is to provide a rigorous and detailed list of assessments, interventions and outcomes which target SSD in children.
In December 2022, a systematic search of Ovid Medline, OVID Embase, CINAHL, PsycInfo and Cochrane and a number of grey literature platforms were undertaken. 18 reviews were included, and subsequently 415 primary research articles were assessed for data related to assessments, interventions or outcomes. The AMSTAR (Assessing the Methodological Quality of Systematic Reviews) framework was used to assess the quality of the retained reviews.
Reviews were retained which took place in any setting.
The population is children of any age with a diagnosis of SSD of unknown origin.
Reviews reporting outcomes, assessment and interventions for children with SSD.
Extraction and analysis identified 37 assessments, 46 interventions and 30 outcome measures used in research reporting of SSD. Not all of the listed outcomes were linked to specific outcome measurement tools, but these were measurable through the use of one or more of the assessments extracted from the retained reviews.
The findings of this review will be used to develop a Core Outcome Set for children with SSD. The findings are part of a rigorous process essential for advancing healthcare research and practice in the specific area of speech and language therapy for children with SSD.
CRD42022316284.
言语障碍（SSD）描述了“言语产生的持续性困难，干扰言语可理解性或妨碍言语交流”。需要确定哪些护理途径对 SSD 儿童最有效和最有效。护理途径的比较需要明确界定、基于证据的干预措施，并就如何衡量结果达成一致。目前，不存在明确的评估、干预或结果清单。本文综述的目的是提供一个严格和详细的清单，其中包括针对儿童 SSD 的评估、干预和结果。
2022 年 12 月，对 Ovid Medline、OVID Embase、CINAHL、PsycInfo 和 Cochrane 以及一些灰色文献平台进行了系统搜索。纳入了 18 篇综述，随后评估了 415 篇主要研究文章，以获取与评估、干预或结果相关的数据。使用 AMSTAR（评估系统评价方法学质量）框架评估保留综述的质量。
保留在任何环境中进行的综述。
研究人群为任何年龄、患有未知病因 SSD 的儿童。
报告 SSD 儿童结局、评估和干预的综述。
提取和分析确定了 37 项评估、46 项干预和 30 项用于 SSD 研究报告的结果测量。列出的所有结果并非都与特定的结果测量工具相关联，但可以通过使用从保留的综述中提取的一个或多个评估来衡量这些结果。
本研究结果将用于为 SSD 儿童制定核心结局集。这些发现是一个严格的过程的一部分，对于推进特定领域的医疗保健研究和实践（即儿童言语和语言治疗中的 SSD）至关重要。
PROSPERO 注册号：CRD42022316284。
